BSG is a vital entrance of SARS-CoV-2 into human cells and is upregulated in both COVID-19 patients and tumor patients (Monteiro et al., 2014; Xin et al., 2016; Bergsneider et al., 2021). Here, BSG is linked to COVID-19.